Leonard J Ferro

**Title: The Innovative Journey of Leonard J. Ferro in Pharmaceutical Development**

Introduction

Leonard J. Ferro, based in Highland Park, IL, is a notable inventor recognized for his significant contributions to the field of pharmaceuticals. His innovations focus on enhancing the delivery and effectiveness of therapeutic compounds, particularly those with low water solubility.

Latest Patents

Ferro holds a patent for the invention titled "Polymorphic crystalline forms of celecoxib." This patent involves pharmaceutical compositions that include one or more orally deliverable dose units, each containing a selective cyclooxygenase-2 inhibitory compound in a therapeutically effective amount. Remarkably, the formulation boasts solid particles, with 25% to 100% by weight measuring less than 1 micrometer. This innovation is particularly valuable for treating ailments associated with cyclooxygenase-2, allowing for a rapid onset of therapeutic effects. The patent describes novel crystalline forms, specifically Form I and Form II, of celecoxib, which exhibit unique chemical and physical properties compared to other forms. Their distinctive features are characterized by powder x-ray diffraction (PXRD) patterns and differential scanning calorimetric (DSC) thermograms among other physical characterizations.

Career Highlights

Leonard Ferro is associated with Pfizer Corporation, a leading global pharmaceutical company. In his role, he focuses on research and development in drug formulation, contributing to advancements in therapeutic applications. His educational and professional background further solidifies his expertise in the pharmaceutical sciences.

Collaborations

Throughout his career, Ferro has collaborated with a diverse group of talented professionals, including his coworker Patricia S. Miyake. These partnerships have facilitated the exchange of ideas and fostered innovation in developing effective pharmaceutical compositions.

Conclusion

Leonard J. Ferro's innovative contributions to the field of pharmaceuticals underscore the importance of advancing drug formulations for improved clinical efficacy. His patent on polymorphic crystalline forms of celecoxib highlights the ongoing efforts to enhance therapeutic outcomes, demonstrating the pivotal role of inventors in addressing healthcare challenges.